Our findings suggest that NF-κB c-Rel plays a critical role in TLR7-mediated inflammation in DCs and warrants consideration of strategies to suppress c-Rel activation as a therapeutic approach in the clinic for psoriasis treatment. The gene discussed is NFKB1; the disease is psoriasis.